Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07376772 · ClinicalTrials.gov registry record · NA
Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
A NA study of Multiple Sclerosis (MS) - Relapsing-remitting and Upper Extremity Dysfunction, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT07376772: Recruiting NA study of Multiple Sclerosis (MS) - Relapsing-remitting and Upper Extremity Dysfunction, sponsored by University of Florida.
NCT07376772 is a NA study of Multiple Sclerosis (MS) - Relapsing-remitting and Upper Extremity Dysfunction that is actively recruiting participants, run by University of Florida. The registered enrollment target is 15 participants, below the 102-participant average among 5 other Multiple Sclerosis (MS) - Relapsing-remitting trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07376772, a NA study of Multiple Sclerosis (MS) - Relapsing-remitting and Upper Extremity Dysfunction, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
This pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for improving upper extremity (UEx) function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS (PRMS) and self-reported UEx impairments will participate in a 4-week FVT program using MyovoltTM wearable FVT devices applied to arm muscles.
Primary Outcome
The Nine-Hole Peg Test (9HPT) assesses fine motor coordination and dexterity by timing how quickly participants can place and remove nine pegs from a pegboard using one hand.
Conditions Studied
Interventions
- DEVICE wearable focal vibration therapy
Study Locations (2)
Florida
- Norman Fixel Institute for Neurological Diseases - Gainesville
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-03-04 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT07376772 shows while recruiting
NCT07376772 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 102-participant average among 5 other Multiple Sclerosis (MS) - Relapsing-remitting trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Multiple Sclerosis (MS) - Relapsing-remitting appearing as the primary indexed condition, and to 1 intervention - of which wearable focal vibration therapy is the first listed.
NCT07376772 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07376772 about?
NCT07376772 is a clinical study titled "Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study". This pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for improving upper extremity (UEx) function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS (...
What is the current status of trial NCT07376772?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2026-03-04. Estimated completion is 2026-06-30.
What conditions does trial NCT07376772 study?
This clinical trial studies the following conditions: Multiple Sclerosis (MS) - Relapsing-remitting, Upper Extremity Dysfunction.
What interventions are being tested in trial NCT07376772?
The interventions under investigation include: wearable focal vibration therapy (DEVICE).
Who is sponsoring clinical trial NCT07376772?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07376772 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis (MS) - Relapsing-remitting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Based Functional Balance Intervention for Multiple Sclerosis
RECRUITING · NA
-
Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery
RECRUITING · NA
-
Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
RECRUITING · Phase 4
-
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
RECRUITING · Early Phase 1
-
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI